Variable clinical presentation of glycogen storage disease type IV: from severe hepatosplenomegaly to cardiac insufficiency. Some discrepancies in genetic and biochemical abnormalities
نویسندگان
چکیده
Corresponding author: Dariusz Rokicki MD, PhD Department of Pediatrics, Nutrition and Metabolic Disorders Children’s Memorial Health Institute Al. Dzieci Polskich 20 04-730 Warsaw, Poland Phone: +48 22 815 75 45 E-mail: [email protected] 1 Department of Pediatrics, Nutrition and Metabolic Disorders, the Children’s Memorial Health Institute, Warsaw, Poland 2 Department of Pathology, the Children’s Memorial Health Institute, Warsaw, Poland 3 Department of Medical Biology, Molecular Biology Laboratory, Institute of Cardiology, Warsaw, Poland 4 Department of Medical Genetics, the Children’s Memorial Health Institute, Warsaw, Poland 5 University Children’s Hospital and Molecular Genetics and Metabolism Laboratory, Munich, Germany 6 Molecular Genetics and Metabolism Laboratory, Munich, Germany 7 Department of Biochemistry, Radioimmunology and Experimental Medicine, the Children’s Memorial Health Institute, Warsaw, Poland 8 Cardiac Magnetic Resonance Unit, Institute of Cardiology, Warsaw, Poland 9 Department of Medical Genetics, Centre of Biostructure, Medical University of Warsaw, Warsaw, Poland 10 Unit for Screening Studies in Inherited Cardiovascular Diseases, Institute of Cardiology, Warsaw, Poland
منابع مشابه
Headache: A Presentation of Pompe Disease; A Case Report
Pompe disease, also termed glycogen storage disease type II or acid maltase deficiency, caused by deficient activity of acid alpha-glucosidase (GAA), the glycogen degrading lysosomal enzyme. As a result, massive lysosomal glycogen deposits in the numerous organs including the muscles. In Pompe disease weakness of truncal muscles is a prominent presentation which results in respiratory failure a...
متن کاملNon-lethal congenital hypotonia due to glycogen storage disease type IV.
Glycogen storage disease type IV (GSD-IV) is an autosomal recessive genetic disorder due to a deficiency in the activity of the glycogen branching enzyme (GBE). A deficiency in GBE activity results in the accumulation of glycogen with fewer branching points and long, unbranched outer chains. The disorder results in a variable phenotype, including musculoskeletal, cardiac, neurological, and hepa...
متن کاملLate-onset Pompe Disease with Elevated Liver Transaminases: A Case Report
Pompe disease or type II glycogen storage disease is a rare autosomal hereditary disease. The prevalence of the disease is about 1 in 40,000 to 1 in 300,000 population. It usually occurs as a result of glycogen accretion following acid maltase deficiency. The current treatment is enzyme replacement therapy, which may slow down the disease progression. Sometimes, the clinical presentation can be...
متن کاملRestoration of muscle functionality by genetic suppression of glycogen synthesis in a murine model of Pompe disease.
Glycogen storage disease type II (GSDII) or Pompe disease is an autosomal recessive disorder caused by acid alpha-glucosidase (GAA) deficiency, leading to lysosomal glycogen accumulation. Affected individuals store glycogen mainly in cardiac and skeletal muscle tissues resulting in fatal hypertrophic cardiomyopathy and respiratory failure in the most severe infantile form. Enzyme replacement th...
متن کاملA New Mutation Causing Severe Infantile-Onset Pompe Disease Responsive to Enzyme Replacement Therapy
Pompe disease (PD), also known as “glycogen storage disease type II (OMIM # 232300)” is a rare autosomal recessive disorder characterized by progressive glycogen accumulation in cellular lysosomes. It ultimately leads to cellular damage. Infantile-onset Pompe disease (IOPD) is the most severe type of this disease and is characterized by severe hypertrophic cardiomyopathy and generalized hypoton...
متن کامل